Literature DB >> 1709099

Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen.

J L Wrana1, C M Overall, J Sodek.   

Abstract

Transforming growth factor beta (TGF-beta) and secreted protein acidic rich cysteine (SPARC) have been associated with the rapid remodeling of connective tissues that occurs in wound healing and developmental processes. To study the temporal and mechanistic aspects of TGF-beta-regulated extracellular-protein gene expression in human fibroblasts, confluent cells were pulse labeled for 30 min with [35S]methionine at various times following the single addition of 1.0 ng/ml TGF-beta. After a 4-h chase period, specific radiolabeled media proteins were isolated by either immunoprecipitation or affinity chromatography and quantitated. Stimulation of SPARC synthesis was first apparent 5 h after addition of TGF-beta, reached a maximum (3.5-fold increase) at 24 h and persisted for at least 96 h. A similar temporal response to TGF-beta was observed for the extracellular matrix proteins collagen and fibronectin. In contrast, TGF-beta induced a strong (greater than sixfold increase at 9 h after addition of TGF-beta), but transient stimulation of the synthesis of endothelial-type plasminogen activator inhibitor. Northern blot analysis showed that SPARC mRNA levels were increased by TGF-beta in parallel with increase in SPARC synthesis; a maximum 3.9-fold increase in SPARC mRNA being reached at 24 h. Similarly, the levels of both collagen and fibronectin mRNA were increased by TGF-beta treatment. In each case the stimulation of mRNA was blocked by the presence of the translation inhibitor, cycloheximide. Stability of SPARC mRNA (half-life of approximately 50 h) was not significantly altered by TGF-beta. In contrast, the stability of collagen and fibronectin mRNA were both increased in the presence of TGF-beta; the increased stability being pronounced in less dense cells. In addition to effects on stability, transcription of the collagen and fibronectin genes was increased 7 h after TGF-beta addition, but returned to control levels by 24 h. However, transcription of the SPARC gene was unaffected by TGF-beta at both time points and, together with the stability data, indicates that TGF-beta regulates SPARC expression via a nuclear post-transcriptional mechanism. Differential regulation of gene expression by TGF-beta in a precise temporal pattern via transcriptional and post-transcriptional pathways may be an important aspect of the response of fibroblast cells in a wound environment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709099     DOI: 10.1111/j.1432-1033.1991.tb15940.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  26 in total

1.  SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Authors:  Barbara J Schiemann; Jason R Neil; William P Schiemann
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

2.  Fibroblast migration after myocardial infarction is regulated by transient SPARC expression.

Authors:  Rong Xue Wu; Martin Laser; Hong Han; Jeeva Varadarajulu; Kai Schuh; Matthias Hallhuber; Kai Hu; Georg Ertl; Christof R Hauck; Oliver Ritter
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

3.  Osteonectin influences growth and invasion of pancreatic cancer cells.

Authors:  Ahmed Guweidhi; Jörg Kleeff; Hassan Adwan; Nathalia A Giese; Moritz N Wente; Thomas Giese; Markus W Büchler; Martin R Berger; Helmut Friess
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

4.  Cell density sensing alters TGF-β signaling in a cell-type-specific manner, independent from Hippo pathway activation.

Authors:  Flore Nallet-Staub; Xueqian Yin; Cristèle Gilbert; Véronique Marsaud; Saber Ben Mimoun; Delphine Javelaud; Edward B Leof; Alain Mauviel
Journal:  Dev Cell       Date:  2015-03-09       Impact factor: 12.270

5.  Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo.

Authors:  M L Iruela-Arispe; T F Lane; D Redmond; M Reilly; R P Bolender; T J Kavanagh; E H Sage
Journal:  Mol Biol Cell       Date:  1995-03       Impact factor: 4.138

6.  Expression of SPARC (secreted protein, acidic and rich in cysteine) in healing intestinal anastomoses and short bowel syndrome in rats.

Authors:  P Puolakkainen; M Reed; P Vento; E H Sage; T Kiviluoto; E Kivilaakso
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

Review 7.  The regulatory function of SPARC in vascular biology.

Authors:  Lee B Rivera; Amy D Bradshaw; Rolf A Brekken
Journal:  Cell Mol Life Sci       Date:  2011-08-06       Impact factor: 9.261

8.  A novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear posttranscriptional event.

Authors:  L A Chandler; C P Ehretsmann; S Bourgeois
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

9.  Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression.

Authors:  Kathleen C Flanders; Lalage M Wakefield
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-25       Impact factor: 2.673

10.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.